130 related articles for article (PubMed ID: 6834584)
21. Combination chemoimmunotherapy of metastatic breast cancer with 5-fluorouracil, adriamycin, cyclophosphamide, and BCG.
Hortobagyi GN; Gutterman JU; Blumenschein GR; Tashima CK; Burgess MA; Einhorn L; Buzdar AU; Richman SP; Hersh EM
Cancer; 1979 Nov; 44(5):1955-62. PubMed ID: 387212
[TBL] [Abstract][Full Text] [Related]
22. [Carcinoembryonic antigen (CEA) in patients with lung cancer: correlation with tumour extent and response to treatment (author's transl)].
Gropp C; Lehmann FG; Havemann K
Dtsch Med Wochenschr; 1977 Jul; 102(30):1079-82. PubMed ID: 891388
[TBL] [Abstract][Full Text] [Related]
23. [The value of carcinoembryonic antigens in patients with advanced lung cancer: in relation to chemotherapy].
Shinkai T; Saijo N; Tominaga K; Eguchi K; Shimizu E; Takahashi K; Sasaki Y; Ohkura H
Gan To Kagaku Ryoho; 1984 May; 11(5):1056-63. PubMed ID: 6202246
[TBL] [Abstract][Full Text] [Related]
24. Comparison of CA15-3 and carcinoembryonic antigen in monitoring the clinical course of patients with metastatic breast cancer.
Tondini C; Hayes DF; Gelman R; Henderson IC; Kufe DW
Cancer Res; 1988 Jul; 48(14):4107-12. PubMed ID: 3164256
[TBL] [Abstract][Full Text] [Related]
25. Sequential use of endocrine therapy and chemotherapy for metastatic breast cancer: effects on survival.
Manni A; Trujillo JE; Pearson OH
Cancer Treat Rep; 1980 Jan; 64(1):111-6. PubMed ID: 6155207
[TBL] [Abstract][Full Text] [Related]
26. Amphotericin B and combination chemotherapy in the treatment of refractory metastatic breast carcinoma and sarcoma.
Krutchik AN; Buzdar AU; Blumenschein GR; Sinkovics JG
Cancer Treat Rep; 1978 Oct; 62(10):1565-7. PubMed ID: 709557
[TBL] [Abstract][Full Text] [Related]
27. [Follow-up of tumor markers in evaluating the effectiveness of chemo- or hormone therapy in metastatic breast cancer].
Möbus V; Paula J; Beck T; Crombach G; Kreienberg R
Geburtshilfe Frauenheilkd; 1993 Jan; 53(1):24-9. PubMed ID: 8440454
[TBL] [Abstract][Full Text] [Related]
28. Serial carcinoembryonic antigen (CEA) determinations in the management of patients with breast cancer.
Staab HJ; Ahlemann LM; Koch HL; Anderer FA
Oncodev Biol Med; 1980; 1(3):151-60. PubMed ID: 7279702
[TBL] [Abstract][Full Text] [Related]
29. [Prognostic value of serum CEA and therapy-induced nonspecific CEA levels in metastasizing breast carcinoma].
Treidler J; Pompecki R; Müllerleile U; Garbrecht M; Kleeberg UR
Onkologie; 1984 Dec; 7(6):328-33. PubMed ID: 6241304
[TBL] [Abstract][Full Text] [Related]
30. A phase III trial of sequential adjuvant chemotherapy for operable breast carcinoma: final analysis with 10-year follow-up.
Assikis V; Buzdar A; Yang Y; Smith T; Theriault R; Booser D; Valero V; Walters R; Singletary E; Ames F; Hortobagyi G
Cancer; 2003 Jun; 97(11):2716-23. PubMed ID: 12767083
[TBL] [Abstract][Full Text] [Related]
31. [A clinicopathological study on carcinoembryonic antigen in breast cancer].
Asagoe T; Yamoto H; Hanatani Y; Horie F; Nemoto A; Kidooka K; Shikata J
Nihon Gan Chiryo Gakkai Shi; 1990 Apr; 25(4):793-8. PubMed ID: 2370434
[TBL] [Abstract][Full Text] [Related]
32. [Diagnostic validity of CEA determination in metastasizing breast cancer].
Krieger G; Prangen M; Klar R; Kneba M; Bandlow G; Nagel GA
Klin Wochenschr; 1986 Aug; 64(15):701-7. PubMed ID: 3762017
[TBL] [Abstract][Full Text] [Related]
33. Phase II clinical and pharmacological study of pirarubicin in combination with 5-fluorouracil and cyclophosphamide in metastatic breast cancer.
Dhingra K; Frye D; Newman RA; Walters R; Theriault R; Fraschini G; Smith T; Buzdar A; Hortobagyi GN
Clin Cancer Res; 1995 Jul; 1(7):691-7. PubMed ID: 9816034
[TBL] [Abstract][Full Text] [Related]
34. Serial CEA determinations as an aid in postoperative therapy management of patients with early breast cancer.
Ahlemann LM; Staab HJ; Anderer FA
Biomedicine; 1980 Dec; 32(4):194-9. PubMed ID: 7470582
[TBL] [Abstract][Full Text] [Related]
35. Carcinoembryonic antigen: an invaluable marker for advanced breast cancer.
Pathak KA; Khanna R; Khanna HD; Khanna S; Gupta S; Khanna NN
J Postgrad Med; 1996; 42(3):68-71. PubMed ID: 9715319
[TBL] [Abstract][Full Text] [Related]
36. [Five-drug therapy in addition to hormonal treatment in advance breast cancer metastatic to the lung (author's transl)].
Matthiessen W; Pochhammer KF
Prax Pneumol; 1976 Aug; 30(8):479-8. PubMed ID: 959156
[No Abstract] [Full Text] [Related]
37. Serial carcinoembryonic antigen (CEA) determinations in the management of metastatic breast cancer.
Lamerz R; Leonhardt A; Ehrhart H; von Lieven H
Oncodev Biol Med; 1980; 1(2):123-35. PubMed ID: 7279699
[TBL] [Abstract][Full Text] [Related]
38. [Changes in carcinoembryonic antigen in patients with breast cancer].
Papaleo G; Zito GA; Gambardella A; Colella C
Boll Soc Ital Biol Sper; 1982 Dec; 58(23):1577-81. PubMed ID: 7165764
[TBL] [Abstract][Full Text] [Related]
39. Treatment of metastatic breast cancer with adriamycin-cyclophosphamide induction followed by alternating combination therapy.
Abeloff MD; Ettinger DS
Cancer Treat Rep; 1977 Dec; 61(9):1685-9. PubMed ID: 340033
[TBL] [Abstract][Full Text] [Related]
40. Effect of different neoadjuvant chemotherapy regimens on locally advanced breast cancer.
Coskun U; Gunel N; Onuk E; Yilmaz E; Bayram O; Yamac D; Cihan A; Ucan B; Yildirim Y; Celenkoglu G; Ozkan S
Neoplasma; 2003; 50(3):210-6. PubMed ID: 12937855
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
